Citations (124)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ahmed Khalil, Mohamed A Hendaus, Emad Elmagboul, Asmaa Mohamed, Anand Deshmukh & Ahmed Elmasoudi. (2019) Incidence Of Clostridium difficile Infection And Associated Risk Factors Among Hospitalized Children In Qatar. Therapeutics and Clinical Risk Management 15, pages 1343-1350.
Read now
Read now
Abubaker O. Abdalla, Sai B. Narala, Mohamed A. Abdallah, Rajkumar Doshi & Nageshwara Gullapalli. (2019) The outcomes of Clostridioides difficile infection in patients with diverticular disease: a nationwide analysis. Scandinavian Journal of Gastroenterology 54:11, pages 1353-1356.
Read now
Read now
Raseen Tariq, Dhruvika Mukhija, Arjun Gupta, Siddharth Singh, Darrell S Pardi & Sahil Khanna. (2018) Statin use and the risk of Clostridium difficile infection: a systematic review with meta-analysis. Infection and Drug Resistance 11, pages 405-416.
Read now
Read now
George Saffouri, Arjun Gupta, Edward V. Loftus$suffix/text()$suffix/text(), Larry M. Baddour, Darrell S. Pardi & Sahil Khanna. (2017) The incidence and outcomes from Clostridium difficile infection in hospitalized adults with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 52:11, pages 1240-1247.
Read now
Read now
Arjun Gupta & Sahil Khanna. (2014) Community-acquired Clostridium difficile infection: an increasing public health threat. Infection and Drug Resistance 7, pages 63-72.
Read now
Read now
Articles from other publishers (119)
Maria Johanna Gobertina Tetuanui Vehreschild, Stefan Schreiber, Lutz von Müller, Hans-Jörg Epple, Thomas Weinke, Carolin Manthey, Jun Oh, Steffen Wahler & Andreas Stallmach. (2023) Trends in the epidemiology of Clostridioides difficile infection in Germany. Infection 51:6, pages 1695-1702.
Crossref
Crossref
Ellen J. Spartz, Lauren C. DeDecker, Kush M. Fansiwala, Shaya Noorian, Andrew R. Roney, Shahrad Hakimian, Jenny S. Sauk, Po‐Hung Chen & Berkeley N. Limketkai. (2023)
Recent trends and risk factors associated with
Clostridioides difficile
infections in hospitalized patients with inflammatory bowel disease
. Alimentary Pharmacology & Therapeutics.
Crossref
Crossref
Abdulaziz Saad Alshahrani, Danah Mohammad, Mohammad attieh Alzahrani & Neeraj Narula. (2023) Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: A retrospective cohort study. Saudi Pharmaceutical Journal 31:9, pages 101736.
Crossref
Crossref
Annelies Boven, Erika Vlieghe, Lars Engstrand, Fredrik L. Andersson, Steven Callens, Johanna Simin & Nele Brusselaers. (2023) Clostridioides difficile infection-associated cause-specific and all-cause mortality: a population-based cohort study. Clinical Microbiology and Infection.
Crossref
Crossref
P Shihabudheen, Faris Hussain, Noushad Babu, Nihal Muhammed, Vivek Prasad, EP Ashique, IP Shahsadhi & FT Shana. (2023) A Case Report on Fulminant Clostridium difficile Colitis Managed with Vancomycin Administered through Ileostomy. Indian Journal of Critical Care Case Report 2:3, pages 66-68.
Crossref
Crossref
Serena Porcari, Andrea Severino, Debora Rondinella, Stefano Bibbò, Gianluca Quaranta, Luca Masucci, Marcello Maida, Franco Scaldaferri, Maurizio Sanguinetti, Antonio Gasbarrini, Giovanni Cammarota & Gianluca Ianiro. (2023) Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis. Journal of Autoimmunity, pages 103033.
Crossref
Crossref
Prathipa Santhanam, Matthew Egberg & Michael D. Kappelman. (2022)
Higher mortality rates associated with
Clostridioides difficile
infection in hospitalized children with cystic fibrosis
. Pediatric Pulmonology 58:2, pages 484-491.
Crossref
Crossref
Theresa Enkirch, Sara Mernelius, Cecilia Magnusson, Sharon Kühlmann‐Berenzon, Malin Bengnér, Thomas Åkerlund & Kristina Rizzardi. (2022)
Molecular epidemiology of community‐ and hospital‐associated
Clostridioides difficile
infections in Jönköping, Sweden, October 2017 – March 2018
. APMIS 130:11, pages 661-670.
Crossref
Crossref
Jinhee Jo, Anne J. Gonzales-Luna, Chris K. Lancaster, Jacob K. McPherson, Khurshida Begum, M. Jahangir Alam & Kevin W. Garey. (2022) Multi-country surveillance of Clostridioides difficile demonstrates high prevalence of spores in non-healthcare environmental settings. Anaerobe 75, pages 102543.
Crossref
Crossref
Deirdre A. Collins, Stephen Marcella, Michael Campbell & Thomas V. Riley. (2022) Linkage study of surveillance and hospital admission data to investigate Clostridium difficile infection in hospital patients in Perth, Western Australia. Anaerobe 74, pages 102528.
Crossref
Crossref
Julie D. Boatman, Michael P. Stevens & John Daniel Markley. 2022. Infection Prevention. Infection Prevention
47
71
.
Syeda Sahra, Mohammad Abureesh, Shivantha Amarnath, Motasem Alkhayyat, Rawan Badran, Abdullah Jahangir & Vivek Gumaste. (2021)
Clostridioides difficile
infection in liver cirrhosis patients: A population-based study in United States
. World Journal of Hepatology 13:8, pages 926-938.
Crossref
Crossref
S. Khanna. (2021)
Microbiota restoration for recurrent
Clostridioides difficile
: Getting one step closer every day!
. Journal of Internal Medicine 290:2, pages 294-309.
Crossref
Crossref
Raseen Tariq, Srishti Saha, Dipesh Solanky, Darrell S. Pardi & Sahil Khanna. (2021) Predictors and Management of Failed Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. Journal of Clinical Gastroenterology 55:6, pages 542-547.
Crossref
Crossref
Karn Wijarnpreecha, Elizabeth S. Aby, Donghee Kim, Patompong Ungprasert, Wisit Cheungpasitporn, Charat Thongprayoon, Frank J. Lukens, Denise M. Harnois & Paul T. Kröner. (2020) The burden of Clostridioides difficile infection in patients with history of liver transplant and during index admission. European Journal of Gastroenterology & Hepatology 33:6, pages 894-898.
Crossref
Crossref
Wisam SBEIT, Anas KADAH, Amir SHAHIN, Nizar ABED, Haya HADDAD, Adel JABBOUR, Helal SAID AHMAD, Rinaldo PELLICANO, Tawfik KHOURY & Amir MARI. (2021) Predictors of in-hospital mortality among patients with clostridium difficile infection: a multicenter study. Minerva Medica 112:1.
Crossref
Crossref
Eunhak Seong, Sookyoung Lim, Myeongjong Lee & Hojun Kim. (2021)
A Study of Antimicrobial Activity of Herbal Extracts on
Clostridium difficile
. Journal of Korean Medicine Rehabilitation 31:1, pages 47-57.
Crossref
Crossref
Hüseyin Bilgin, Elvan Sayın, Hande Perk Gürün, Elif Tükenmez-Tigen, Nurver Ülger Toprak & Volkan Korten. (2020) Hospital acquired Clostridioides difficile infection and risk factors for severity in a university hospital: A prospective study. American Journal of Infection Control 48:12, pages 1426-1430.
Crossref
Crossref
Soomin Lee, Heeyoung Lee, Sejeong Kim, Jeeyeon Lee, Jimyeong Ha, Yukyung Choi, Hyemin Oh, Yujin Kim, Yewon Lee, Kyoung-Hee Choi & Yohan Yoon. (2020)
Intestinal
Clostridioides difficile
Can Cause Liver Injury through the Occurrence of Inflammation and Damage to Hepatocytes
. BioMed Research International 2020, pages 1-11.
Crossref
Crossref
Raseen Tariq, Molly B Disbrow, John K Dibaise, Robert Orenstein, Srishti Saha, Dipesh Solanky, Edward V Loftus, Darrell S Pardi & Sahil Khanna. (2020) Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 26:9, pages 1415-1420.
Crossref
Crossref
Parkpoom PhatharacharukulRussell D. PurpuraDevika GandhiHuiping XuKatie Bickett-BurkhartNaga ChalasaniMonika FischerEric S. Orman. (2020) Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis. Clinical and Translational Gastroenterology 11:7, pages e00189.
Crossref
Crossref
Francesca Valent. (2020) A population-based study of the incidence of laboratory-confirmed Clostridium difficile infections and their recurrence in the Italian province of Udine. Anaerobe 61, pages 102144.
Crossref
Crossref
Ravina Kullar & Ellie J. C. Goldstein. 2020. Clostridium Difficile Infection in Long-Term Care Facilities. Clostridium Difficile Infection in Long-Term Care Facilities
25
36
.
Maureen Hitschfeld, Elena Tovar, Sarah Gupta, Elisabeth M. Bik, Christina Palmer, Michael C. Hoaglin, Daniel E. Almonacid, Jessica Richman & Zachary S. Apte. (2019) The role of a sequencing-based clinical intestinal screening test in patients at high-risk for Clostridium difficile and other pathogens: a case report. Journal of Medical Case Reports 13:1.
Crossref
Crossref
Christian Breuer, Sabrina Döring, Holger Rohde, Stefan Rutkowski, Ingo Müller & Jun Oh. (2019) Clostridium difficile infection after pediatric solid organ transplantation: a practical single-center experience. Pediatric Nephrology 34:7, pages 1269-1275.
Crossref
Crossref
Dipesh Solanky, Darrell S Pardi, Edward V LoftusJrJr & Sahil Khanna. (2019) Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection. Inflammatory Bowel Diseases 25:3, pages 610-619.
Crossref
Crossref
Mohammed Qutub, Prasanth Govindan & Anupama Vattappillil. (2019) Effectiveness of a Two-Step Testing Algorithm for Reliable and Cost-Effective Detection of Clostridium difficile Infection in a Tertiary Care Hospital in Saudi Arabia. Medical Sciences 7:1, pages 6.
Crossref
Crossref
Nathaniel Aviv Cohen & Nitsan Maharshak. 2019. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications
177
184
.
Aela P. Vely & Paula Ferrada. 2019. Emergency General Surgery. Emergency General Surgery
277
281
.
Eric J. Battaglioli, Vanessa L. Hale, Jun ChenPatricio Jeraldo, Coral Ruiz-MojicaBradley A. SchmidtVayu M. Rekdal, Lisa M. Till, Lutfi Huq, Samuel A. Smits, William J. MoorYava Jones-Hall, Thomas Smyrk, Sahil KhannaDarrell S. PardiMadhusudan Grover, Robin PatelNicholas ChiaHeidi NelsonJustin L. Sonnenburg, Gianrico Farrugia & Purna C. Kashyap. (2018)
Clostridioides difficile
uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea
. Science Translational Medicine 10:464.
Crossref
Crossref
E. Ofori, D. Ramai, M. Dhawan, F. Mustafa, J. Gasperino & M. Reddy. (2018) Community-acquired Clostridium difficile: epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapies. Journal of Hospital Infection 99:4, pages 436-442.
Crossref
Crossref
Grant E Barber, Steven Hendler, Philip Okafor, David Limsui & Berkeley N Limketkai. (2018) Rising Incidence of Intestinal Infections in Inflammatory Bowel Disease: A Nationwide Analysis. Inflammatory Bowel Diseases 24:8, pages 1849-1856.
Crossref
Crossref
Eunyoung Lee, Kyoung-Ho Song, Ji Yun Bae, Doran Yoon, Joo-Hee Hwang, Pyoeng Gyun Choe, Wan Beom Park, Ji Hwan Bang, Eu Suk Kim, Sang Won Park, Nam Joong Kim, Myoung-don Oh & Hong Bin Kim. (2018) Risk factors for poor outcome in community-onset Clostridium difficile infection. Antimicrobial Resistance & Infection Control 7:1.
Crossref
Crossref
Anca Trifan, Irina Girleanu, Carol Stanciu, Egidia Miftode, Camelia Cojocariu, Ana‐Maria Singeap, Catalin Sfarti, Stefan Chiriac, Tudor Cuciureanu & Oana Stoica. (2017)
Clostridium difficile
infection in hospitalized octogenarian patients
. Geriatrics & Gerontology International 18:2, pages 315-320.
Crossref
Crossref
Nitsan Maharshak, Idan Barzilay, Hasya Zinger, Keren Hod & Iris Dotan. (2018) Clostridium difficile infection in hospitalized patients with inflammatory bowel disease. Medicine 97:5, pages e9772.
Crossref
Crossref
Katherine A. Kirkwood, Brian C. Gulack, Alexander Iribarne, Michael E. Bowdish, Giampaolo Greco, Mary Lou Mayer, Karen O'Sullivan, Annetine C. Gelijns, Nishit Fumakia, Ravi K. Ghanta, Jesse M. Raiten, Anuradha Lala, Joseph S. Ladowski, Eugene H. Blackstone, Michael K. Parides, Alan J. Moskowitz & Keith A. Horvath. (2018) A multi-institutional cohort study confirming the risks of Clostridium difficile infection associated with prolonged antibiotic prophylaxis. The Journal of Thoracic and Cardiovascular Surgery 155:2, pages 670-678.e1.
Crossref
Crossref
John Daniel Markley & Michael P. Stevens. 2018. Infection Prevention. Infection Prevention
35
53
.
Sepideh Pakpour, Amit Bhanvadia, Roger Zhu, Abhimanyu Amarnani, Sean M. Gibbons, Thomas Gurry, Eric J. Alm & Laura A. Martello. (2017) Identifying predictive features of Clostridium difficile infection recurrence before, during, and after primary antibiotic treatment. Microbiome 5:1.
Crossref
Crossref
Raseen Tariq, Darrell S Pardi, Pritish K Tosh, Randall C Walker, Raymund R Razonable & Sahil Khanna. (2017) Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency. Clinical Infectious Diseases 65:10, pages 1745-1747.
Crossref
Crossref
Anca Trifan, Carol Stanciu, Irina Girleanu, Oana Cristina Stoica, Ana Maria Singeap, Roxana Maxim, Stefan Andrei Chiriac, Alin Ciobica & Lucian Boiculese. (2017) Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis. World Journal of Gastroenterology 23:35, pages 6500-6515.
Crossref
Crossref
Laura Palau Dávila, Elvira Garza-González, Patricia Rodríguez-Zulueta, Rayo Morfín-Otero, Eduardo Rodríguez-Noriega, Diana Vilar-Compte, Juan C. Rodríguez-Aldama & Adrián Camacho-Ortiz. (2017) Increasing rates of Clostridium difficile infection in Mexican hospitals. The Brazilian Journal of Infectious Diseases 21:5, pages 530-534.
Crossref
Crossref
Małgorzata Aptekorz, Anna Szczegielniak, Barbara Wiechuła, Celine Harmanus, Ed Kuijper & Gayane Martirosian. (2017) Occurrence of Clostridium difficile ribotype 027 in hospitals of Silesia, Poland. Anaerobe 45, pages 106-113.
Crossref
Crossref
Vamsi Krishna Kantamaneni, Krishna C Gurram & Abhijit Kulkarni. (2017)
Clostridium difficile
extraintestinal abscess: a rare complication
. BMJ Case Reports, pages bcr-2017-219957.
Crossref
Crossref
K. A. Morris, L. R. Macfarlane-Smith & M. H. Wilcox. (2016) Evaluation of the novel artus C. difficile QS-RGQ, VanR QS-RGQ and MRSA/SA QS-RGQ assays for the laboratory diagnosis of Clostridium difficile infection (CDI), and for vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) screening. European Journal of Clinical Microbiology & Infectious Diseases 36:5, pages 823-829.
Crossref
Crossref
Paul Yang, Sara Hash, Katherine Park, Charlene Wong, Loganathan Doraisamy, Jonas Petterson, Cathy A. Petti, Pamela M. Ward, Seung Heon Lee, Suresh Menon & Rosemary C. She. (2017) Application of Nuclear Magnetic Resonance to Detect Toxigenic Clostridium difficile from Stool Specimens. The Journal of Molecular Diagnostics 19:2, pages 230-235.
Crossref
Crossref
Stephen M. Vindigni & Christina M. Surawicz. (2017) Fecal Microbiota Transplantation. Gastroenterology Clinics of North America 46:1, pages 171-185.
Crossref
Crossref
Nicola Petrosillo & Roberto Ravasio. (2017)
Il Costo Ospedaliero di Trattamento di un Episodio di Infezione da
Clostridium Difficile
in Italia
. Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish 4:1, pages grhta.5000257.
Crossref
Crossref
William Gillespie, Neil Marya, Julien Fahed, Gregory Leslie, Krunal Patel & David R. Cave. (2017)
Clostridium difficile
in Inflammatory Bowel Disease: A Retrospective Study
. Gastroenterology Research and Practice 2017, pages 1-5.
Crossref
Crossref
Mark H. Wilcox, James D. Chalmers, Carl E. Nord, Jane Freeman & Emilio Bouza. (2017)
Role of cephalosporins in the era of
Clostridium difficile
infection
. Journal of Antimicrobial Chemotherapy 72:1, pages 1-18.
Crossref
Crossref
Raseen Tariq & Sahil Khanna. (2016) Clostridium difficile infection: Updates in management. Indian Journal of Gastroenterology 36:1, pages 3-10.
Crossref
Crossref
Jorge Silva-VelazcoTracy L. HullCraig Messick & James M. Church. (2016) Medical versus Surgical Patients with Clostridium difficile Infection: Is There Any Difference?. The American Surgeon 82:12, pages 1155-1159.
Crossref
Crossref
Teena Chopra, Ellie J.C. Goldstein & Sherwood L. Gorbach. (2016)
Rethinking Strategies to Select Antibiotic Therapy in
Clostridium difficile
infection
. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36:12, pages 1281-1289.
Crossref
Crossref
Andreas Otto, Sandra Maaß, Christian Lassek, Dörte Becher, Michael Hecker, Katharina Riedel & Susanne Sievers. (2016)
The protein inventory of
Clostridium difficile
grown in complex and minimal medium
. PROTEOMICS - Clinical Applications 10:9-10, pages 1068-1072.
Crossref
Crossref
A. Wadhwa, M. F. Al Nahhas, R. A. Dierkhising, R. Patel, P. Kashyap, D. S. Pardi, S. Khanna & M. Grover. (2016)
High risk of post‐infectious irritable bowel syndrome in patients with
Clostridium difficile
infection
. Alimentary Pharmacology & Therapeutics 44:6, pages 576-582.
Crossref
Crossref
Lauren E. Bloomfield & Thomas V. Riley. (2016) Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review. Infectious Diseases and Therapy 5:3, pages 231-251.
Crossref
Crossref
Paul O. Lewis, John M. Litchfield, Jennifer L. Tharp, Rebecca M. Garcia, Mohsen Pourmorteza & Chakradhar M. Reddy. (2016)
Risk and Severity of Hospital-Acquired
Clostridium difficile
Infection in Patients Taking Proton Pump Inhibitors
. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36:9, pages 986-993.
Crossref
Crossref
Sahil Khanna, Arjun Gupta, Larry M. Baddour & Darrell S. Pardi. (2015) Epidemiology, outcomes, and predictors of mortality in hospitalized adults with Clostridium difficile infection. Internal and Emergency Medicine 11:5, pages 657-665.
Crossref
Crossref
Tian-tian Tian, Jian-hong Zhao, Jing Yang, Cui-xin Qiang, Zhi-rong Li, Jing Chen, Kai-yue Xu, Qing-qing Ciu & Ru-xin Li. (2016) Molecular Characterization of Clostridium difficile Isolates from Human Subjects and the Environment. PLOS ONE 11:3, pages e0151964.
Crossref
Crossref
Yu Mi Lee, Kyu Chan Huh, Soon Man Yoon, Byung Ik Jang, Jeong Eun Shin, Hoon Sup Koo, Yunho Jung, Sae Hee Kim, Hee Seok Moon & Seung Woo Lee. (2016) Incidence and Clinical Outcomes of Clostridium difficile Infection after Treatment with Tuberculosis Medication. Gut and Liver 10:2, pages 250.
Crossref
Crossref
Abhik Roy & Simon Lichtiger. (2016) Clostridium difficile Infection. Inflammatory Bowel Diseases 22:3, pages 648-653.
Crossref
Crossref
Sachin VaidJohn Sung Park & Robert John Sinnott. (2016) Outcomes of Recurrent Rectal Cancer after Transanal Excision. The American Surgeon 82:2, pages 152-155.
Crossref
Crossref
Francesca Mangiola. (2016) Gut microbiota in autism and mood disorders. World Journal of Gastroenterology 22:1, pages 361.
Crossref
Crossref
M. Chmielewska, K. Zycinska, B. Lenartowicz, M. Hadzik-Błaszczyk, M. Cieplak, Z. Kur & K. A. Wardyn. 2017. Pathobiology of Pulmonary Disorders. Pathobiology of Pulmonary Disorders
59
63
.
Agata Kujawa-Szewieczek, Marcin Adamczak, Katarzyna Kwiecień, Sylwia Dudzicz, Magdalena Gazda & Andrzej Więcek. (2015) The Effect of Lactobacillus plantarum 299v on the Incidence of Clostridium difficile Infection in High Risk Patients Treated with Antibiotics. Nutrients 7:12, pages 10179-10188.
Crossref
Crossref
Bruce E Hirsch, Nimit Saraiya, Kaitlin Poeth, Rebecca M Schwartz, Marcia E Epstein & Gerard Honig. (2015) Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection. BMC Infectious Diseases 15:1.
Crossref
Crossref
A. Trifan, O. Stoica, C. Stanciu, C. Cojocariu, A.-M. Singeap, I. Girleanu & E. Miftode. (2015) Clostridium difficile infection in patients with liver disease: a review. European Journal of Clinical Microbiology & Infectious Diseases 34:12, pages 2313-2324.
Crossref
Crossref
WEI CHEN, WEN-EN LIU, YAN-MING LI, SHAN LUO & YI-MING ZHONG. (2015) Preparation and preliminary application of monoclonal antibodies to the receptor binding region of Clostridium difficile toxin B. Molecular Medicine Reports 12:5, pages 7712-7720.
Crossref
Crossref
Glenn Magee, Marcie E. Strauss, Sheila M. Thomas, Harold Brown, Dorothy Baumer & Kelly C. Broderick. (2015) Impact of Clostridium difficile-associated diarrhea on acute care length of stay, hospital costs, and readmission: A multicenter retrospective study of inpatients, 2009-2011. American Journal of Infection Control 43:11, pages 1148-1153.
Crossref
Crossref
Stephen M Vindigni & Christina M Surawicz. (2015) C. difficile Infection: Changing Epidemiology and Management Paradigms. Clinical and Translational Gastroenterology 6:7, pages e99.
Crossref
Crossref
Angel Asensio, Stefano Di Bella, Andrea Lo Vecchio, Santiago Grau, Warren M. Hart, Beatriz Isidoro, Ricardo Scotto, Nicola Petrosillo, Maureen Watt & Jameel Nazir. (2015) The impact of Clostridium difficile infection on resource use and costs in hospitals in Spain and Italy: a matched cohort study. International Journal of Infectious Diseases 36, pages 31-38.
Crossref
Crossref
Natalia N. Egorova, Jeffrey J. Siracuse, James F. McKinsey & Roman Nowygrod. (2015) Trend, Risk Factors, and Costs of Clostridium difficile Infections in Vascular Surgery. Annals of Vascular Surgery 29:4, pages 792-800.
Crossref
Crossref
R. Wilson, P. Beerbaum & S. Giglio. (2015)
Community and hospital acquired
Clostridium difficile
in South Australia - ribotyping of isolates and a comparison of laboratory detection methods
. Letters in Applied Microbiology 60:1, pages 33-36.
Crossref
Crossref
Courtney E. Collins, M. Didem Ayturk, Fred A. AndersonJr.Jr. & Heena P. Santry. (2014) Predictors and Outcomes of Readmission for Clostridium difficile in a National Sample of Medicare Beneficiaries. Journal of Gastrointestinal Surgery 19:1, pages 88-99.
Crossref
Crossref
Arjun Gupta, Robin Patel, Larry M. Baddour, Darrell S. Pardi & Sahil Khanna. (2014) Extraintestinal Clostridium difficile Infections: A Single-Center Experience. Mayo Clinic Proceedings 89:11, pages 1525-1536.
Crossref
Crossref
Andrew Flagg, Colleen G. Koch, Nicholas Schiltz, Aiswarya Chandran Pillai, Steven M. Gordon, Gösta B. Pettersson & Edward G. Soltesz. (2014) Analysis of Clostridium difficile infections after cardiac surgery: Epidemiologic and economic implications from national data. The Journal of Thoracic and Cardiovascular Surgery 148:5, pages 2404-2409.
Crossref
Crossref
Kathleen B. ToLena M. Napolitano. (2014)
Clostridium difficile
Infection: Update on Diagnosis, Epidemiology, and Treatment Strategies
. Surgical Infections 15:5, pages 490-502.
Crossref
Crossref
Achuta Kumar Guddati, Gagan Kumar, Shahryar Ahmed, Muhammad Ali, Nilay Kumar, Parameswaran Hari & Nanda Venu. (2014) Incidence and outcomes of Clostridium difficile-associated disease in hematopoietic cell transplant recipients. International Journal of Hematology 99:6, pages 758-765.
Crossref
Crossref
S. Lital Meyer, A. Ricardo Espinoza & P. Rodrigo Quera. (2014) Infección por clostridium difficile: epidemiología, diagnóstico y estrategias terapéuticas. Revista Médica Clínica Las Condes 25:3, pages 473-484.
Crossref
Crossref
C. Bermejo, E. Maseda, P. Salgado, G. Gabilondo & F. Gilsanz. (2014) Shock séptico debido a la infección por Clostridium difficile adquirida en la comunidad. Estudio de un caso y revisión de la literatura. Revista Española de Anestesiología y Reanimación 61:4, pages 219-222.
Crossref
Crossref
Kathleen Mullane. (2013)
Fidaxomicin in
Clostridium difficile
infection: latest evidence and clinical guidance
. Therapeutic Advances in Chronic Disease 5:2, pages 69-84.
Crossref
Crossref
Sahil Khanna & Darrell S. Pardi. (2013)
Clostridium difficile
infection: management strategies for a difficult disease
. Therapeutic Advances in Gastroenterology 7:2, pages 72-86.
Crossref
Crossref
Anca Trifan. (2014)
Impact of
Clostridium difficile
infection on inflammatory bowel disease outcome: A review
. World Journal of Gastroenterology 20:33, pages 11736.
Crossref
Crossref
Mark J. Koenigsknecht & Vincent B. Young. (2013) Faecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection. Current Opinion in Gastroenterology 29:6, pages 628-632.
Crossref
Crossref
Raina Shivashankar, Sahil Khanna, Patricia P. Kammer, W. Scott Harmsen, Alan R. Zinsmeister, Larry M. Baddour & Darrell S. Pardi. (2013) Clinical Factors Associated With Development of Severe-Complicated Clostridium difficile Infection. Clinical Gastroenterology and Hepatology 11:11, pages 1466-1471.
Crossref
Crossref
Brett G. Mitchell, Anne Gardner & Janet E. Hiller. (2013)
Mortality and
Clostridium difficile
infection in an Australian setting
. Journal of Advanced Nursing 69:10, pages 2162-2171.
Crossref
Crossref
S. Di Bella, F. Taglietti & N. Petrosillo. (2013) Are There Reasons To Prefer Tetracyclines to Macrolides in Older Patients with Community-Acquired Pneumonia?. Antimicrobial Agents and Chemotherapy 57:8, pages 4093-4093.
Crossref
Crossref
Burnham D. Carey-Ann & Karen C. Carroll. (2013) Diagnosis of Clostridium difficile Infection: an Ongoing Conundrum for Clinicians and for Clinical Laboratories. Clinical Microbiology Reviews 26:3, pages 604-630.
Crossref
Crossref
Sahil Khanna, Mira T. Keddis, Amit Noheria, Larry M. Baddour & Darrell S. Pardi. (2013) Acute Kidney Injury is an Independent Marker of Severity in Clostridium difficile Infection. Journal of Clinical Gastroenterology 47:6, pages 481-484.
Crossref
Crossref
Julia Shaklee Sammons, Russell Localio, Rui Xiao, Susan E. Coffin & Theoklis Zaoutis. (2013) Clostridium difficile Infection Is Associated With Increased Risk of Death and Prolonged Hospitalization in Children. Clinical Infectious Diseases 57:1, pages 1-8.
Crossref
Crossref
L. Patrick Schenck, S. A. Hirota, C. L. Hirota, P. Boasquevisque, S. E. Tulk, Y. Li, A. Wadhwani, C. T. A. Doktorchik, W. K. MacNaughton, P. L. Beck & J. A. MacDonald. (2013)
Attenuation of
Clostridium difficile
toxin‐induced damage to epithelial barrier by ecto‐5′‐nucleotidase (
CD
73) and adenosine receptor signaling
. Neurogastroenterology & Motility 25:6.
Crossref
Crossref
Sahil Khanna, Larry M. Baddour, W. Charles Huskins, Patricia P. Kammer, William A. Faubion, Alan R. Zinsmeister, W. Scott Harmsen & Darrell S. Pardi. (2013) The Epidemiology of Clostridium difficile Infection in Children: A Population-Based Study. Clinical Infectious Diseases 56:10, pages 1401-1406.
Crossref
Crossref
Brianne Couturier, Robert Schlaberg, Chris Konzak, Jeff Nicholes, Christian Law & Rosemary C. She. (2013)
tcdA
As a Diagnostic Target in a Loop-Mediated Amplification Assay for Detecting Toxigenic
Clostridium difficile
. Journal of Clinical Laboratory Analysis 27:3, pages 171-176.
Crossref
Crossref
Chaitanya Pant, Michael P. Anderson, Abhishek Deshpande, Muhammad A. Altaf, John E. Grunow, Ashish Atreja & Thomas J. Sferra. (2013) Health Care Burden of Clostridium difficile Infection in Hospitalized Children with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 19:5, pages 1080-1085.
Crossref
Crossref
Arch G MainousIIIIII, Carol A Lambourne & Paul J Nietert. (2013) Impact of a clinical decision support system on antibiotic prescribing for acute respiratory infections in primary care: quasi-experimental trial. Journal of the American Medical Informatics Association 20:2, pages 317-324.
Crossref
Crossref
Katie Solomon. (2013)
The host immune response to
Clostridium difficile
infection
. Therapeutic Advances in Infectious Disease 1:1, pages 19-35.
Crossref
Crossref
Thomas J. Louie, Mark A. Miller, Derrick W. Crook, Arnold Lentnek, Louis Bernard, Kevin P. High, Youe‐Kong Shue & Sherwood L. Gorbach. (2013)
Effect of Age on Treatment Outcomes in
C
lostridium difficile
Infection
. Journal of the American Geriatrics Society 61:2, pages 222-230.
Crossref
Crossref
Edward W. Chu, Brett L. Ecker, Malika Garg & Celia M. Divino. (2012) The Surgical Management of Active Ulcerative Colitis Complicated by Clostridium difficile Infection. Journal of Gastrointestinal Surgery 17:2, pages 392-396.
Crossref
Crossref
S. Khanna & D. S. Pardi. (2012) "Community-Acquired Clostridium difficile Infection: An Emerging Entity". Clinical Infectious Diseases 55:12, pages 1741-1742.
Crossref
Crossref
Randeep S. Jawa & David W. Mercer. (2012) Clostridium difficile–associated infection: a disease of varying severity. The American Journal of Surgery 204:6, pages 836-842.
Crossref
Crossref
Alizah Rotramel, Lisa S. Poritz, Evangelos Messaris, Arthur Berg & David B. Stewart. (2012) PPI Therapy and Albumin are Better Predictors of Recurrent Clostridium difficile Colitis than Choice of Antibiotics. Journal of Gastrointestinal Surgery 16:12, pages 2267-2273.
Crossref
Crossref
Angela E. Reeves, Mark J. Koenigsknecht, Ingrid L. Bergin & Vincent B. Young. (2012) Suppression of Clostridium difficile in the Gastrointestinal Tracts of Germfree Mice Inoculated with a Murine Isolate from the Family Lachnospiraceae. Infection and Immunity 80:11, pages 3786-3794.
Crossref
Crossref
Sahil Khanna & Darrell S. Pardi. (2012) Clostridium difficile Infection: New Insights Into Management. Mayo Clinic Proceedings 87:11, pages 1106-1117.
Crossref
Crossref
Mira T. Keddis, Sahil Khanna, Amit Noheria, Larry M. Baddour, Darrell S. Pardi & Qi Qian. (2012) Clostridium difficile Infection in Patients With Chronic Kidney Disease. Mayo Clinic Proceedings 87:11, pages 1046-1053.
Crossref
Crossref
Miguel Bispo. (2012) Aumento alarmante da incidência da diarreia associada ao clostridium difficile em Portugal. GE Jornal Português de Gastrenterologia 19:6, pages 276-277.
Crossref
Crossref
Franco Scaldaferri, Marco Pizzoferrato, Silvia Pecere, Fabrizio Forte & Antonio Gasbarrini. (2012) Bacterial Flora as a Cause or Treatment of Chronic Diarrhea. Gastroenterology Clinics of North America 41:3, pages 581-602.
Crossref
Crossref
Jeffrey S. Weissman & Walter Coyle. (2012) Stool Transplants: Ready for Prime Time?. Current Gastroenterology Reports 14:4, pages 313-316.
Crossref
Crossref
Muhammad Ali, Ashwin N. Ananthakrishnan, Shahryar Ahmad, Nilay Kumar, Gagan Kumar & Kia Saeian. (2012) Clostridium difficile infection in hospitalized liver transplant patients: A nationwide analysis. Liver Transplantation 18:8, pages 972-978.
Crossref
Crossref
Sahil Khanna, Scott L. Aronson, Patricia P. Kammer, Larry M. Baddour & Darrell S. Pardi. (2012) Gastric Acid Suppression and Outcomes in Clostridium difficile Infection: A Population-Based Study. Mayo Clinic Proceedings 87:7, pages 636-642.
Crossref
Crossref
Kathryn T. Chen, Daniel J. Stephens, Eric Anderson, Robert Acton, Daniel Saltzman & Donavon J. Hess. (2012) Clostridium difficile infection in the pediatric surgery population. Journal of Pediatric Surgery 47:7, pages 1385-1389.
Crossref
Crossref
Reetta Huttunen, Risto Vuento, Jaana Syrjänen, Päivi Tissari & Janne Aittoniemi. (2012) Case fatality associated with a hypervirulent strain in patients with culture-positive Clostridium difficile infection: a retrospective population-based study. International Journal of Infectious Diseases 16:7, pages e532-e535.
Crossref
Crossref
Sahil Khanna & Darrell S. Pardi. (2012) Poor outcomes after Clostridium difficile infection in IBD. Nature Reviews Gastroenterology & Hepatology 9:6, pages 307-308.
Crossref
Crossref
Kevork M. Peltekian. (2012) Clostridium difficile on the Transplantation Radar. Transplantation 93:10, pages 974-975.
Crossref
Crossref
S. Khanna, D. S. Pardi, S. L. Aronson, P. P. Kammer & L. M. Baddour. (2012) Outcomes in community-acquired Clostridium difficile infection. Alimentary Pharmacology & Therapeutics 35:5, pages 613-618.
Crossref
Crossref
Daniel M. Autenrieth & Daniel C. Baumgart. (2012) Toxic megacolon. Inflammatory Bowel Diseases 18:3, pages 584-591.
Crossref
Crossref
Vicki R. Kee. (2012) Clostridium Difficile Infection in Older Adults: A Review and Update on Its Management. The American Journal of Geriatric Pharmacotherapy 10:1, pages 14-24.
Crossref
Crossref
Brett G Mitchell & Anne Gardner. (2012) Mortality and Clostridium difficile infection: a review. Antimicrobial Resistance and Infection Control 1:1, pages 20.
Crossref
Crossref
Sahil Khanna, Darrell S Pardi, Scott L Aronson, Patricia P Kammer, Robert Orenstein, Jennifer L St Sauver, Scott W Harmsen & Alan R Zinsmeister. (2012) The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study. American Journal of Gastroenterology 107:1, pages 89-95.
Crossref
Crossref
Rada Shakov, Raquel S. Salazar, Silvester K. Kagunye, Walid J. Baddoura & Vincent A. DeBari. (2011) Diabetes mellitus as a risk factor for recurrence of Clostridium difficile infection in the acute care hospital setting. American Journal of Infection Control 39:3, pages 194-198.
Crossref
Crossref
N. Esther Babady, Jeffrey Stiles, Phyllis Ruggiero, Perminder Khosa, David Huang, Susan Shuptar, Mini Kamboj & Timothy E. Kiehn. (2010)
Evaluation of the Cepheid Xpert
Clostridium difficile
Epi Assay for Diagnosis of
Clostridium difficile
Infection and Typing of the NAP1 Strain at a Cancer Hospital
. Journal of Clinical Microbiology 48:12, pages 4519-4524.
Crossref
Crossref